Genedrive plc has been awarded additional funding under the DEVOTE programme, a collaboration aimed at integrating genomic technology into clinical practice. The company received approximately £1.2 ...

Their products, such as the Genedrive® MT-RNR1 ID Kit and the Genedrive® CYP2C19 ID Kit, are designed to assist clinicians in making informed decisions about medication use, particularly in ...

Data on rare, less frequent alleles can be found at [101]. CYP2C19-mediated interactions Ticlopidine ↑ PPI effect Inhibition of omeprazole 5'-hydroxylation, decreased elimination Increased ...

(Alliance News) - Genedrive PLC on Wednesday announced follow-on funding of GBP200,000 for further improvements to user experiences in rapid genetic testing environments.